Skip to content

Scholar Rock SRRK Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Biogen logo
BiogenBIIB
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Arrowhead Research logo
Arrowhead ResearchARWR
Roivant Sciences logo
Roivant SciencesROIV

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's deferred tax assets and other non-current assets?
Scholar Rock (SRRK) reported deferred tax assets and other non-current assets of $4.59M in Q1 2026.
How has Scholar Rock's deferred tax assets and other non-current assets changed year-over-year?
Scholar Rock's deferred tax assets and other non-current assets increased by 60.6% year-over-year, from $2.86M to $4.59M.
What is the long-term trend for Scholar Rock's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Scholar Rock's deferred tax assets and other non-current assets has grown at a 25.9% compound annual growth rate (CAGR), from $1.02M to $3.23M.